Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells

Biochemical and Biophysical Research Communications

Volumn 335, Issue 4, 2005, Pages 1115-1122

  Eshel, Rinat ^a   Ben Zaken, Olga ^b   Vainas, Oded ^a   Nadir, Yona ^d   Minucci, Saverio ^f   Polliack, Aaron ^b   Naparstek, Ella ^a   Vlodavsky, Israel ^e   Katz, Ben Zion ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Heparanase; Histone deacetylation; Leukemia; Myeloid; Regulation; Transcription

Indexed keywords

DNA; HEPARANASE; HISTONE DEACETYLASE INHIBITOR; ONCOPROTEIN; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; DOWN REGULATION; FUSION GENE; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

EID: 24044500319     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.004     Document Type: Article

References (34)

1. R.V. Iozzo Matrix proteoglycans: from molecular design to cellular function Annu. Rev. Biochem. 67 1998 609 652
2. G. David Integral membrane heparan sulfate proteoglycans FASEB J. 7 1993 1023 1030
3. I. Vlodavsky, and Y. Friedmann Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis J. Clin. Invest. 108 2001 341 347
4. C.R. Parish, C. Freeman, and M.D. Hulett Heparanase: a key enzyme involved in cell invasion Biochim. Biophys. Acta 1471 2001 M99 M108
5. I. Vlodavsky, A. Eldor, A. Haimovitz-Friedman, Y. Matzner, R. Ishai-Michaeli, O. Lider, Y. Naparstek, I.R. Cohen, and Z. Fuks Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation Invasion Metastasis 12 1992 112 127
6. M. Bitan, A. Polliack, G. Zecchina, A. Nagler, Y. Friedmann, L. Nadav, V. Deutsch, I. Pecker, A. Eldor, I. Vlodavsky, and B.Z. Katz Heparanase expression in human leukemias is restricted to acute myeloid leukemias Exp. Hematol. 30 2002 34 41
7. M. Ruthardt, U. Testa, C. Nervi, P. Ferrucci, F. Grignani, E. Puccetti, C. Peschle, and P.G. Pelicci Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling Mol. Cell. Biol. 17 1997 4859 4869
8. S. Minucci, C. Nervi, F. Lo Coco, and P.G. Pelicci Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene 20 2001 3110 3115
9. K. Georgopoulos Haematopoietic cell-fate decisions, chromatin regulation and ikaros Nat. Rev. Immunol. 2 2002 162 174
10. R. Fenrick, and S.W. Hiebert Role of histone deacetylases in acute leukemia J. Cell. Biochem. 31 1998 194 202
11. H. Li, and J.D. Chen PML and the oncogenic nuclear domains in regulating transcriptional repression Curr. Opin. Cell Biol. 12 2000 641 644
12. P. Salomoni, and P.P. Pandolfi The role of PML in tumor suppression Cell 108 2002 165 170
13. J.H. Jansen, and B. Lowenberg Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein Semin. Hematol. 38 2001 37 41
14. P. Fenaux, C. Chastang, C. Chomienne, S. Castaigne, M. Sanz, H. Link, B. Lowenberg, M. Fey, E. Archim-Baud, and L. Degos Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy Leuk. Lymphoma 16 1995 431 437
15. W.S. Wu, S. Vallian, E. Seto, W.M. Yang, D. Edmondson, S. Roth, and K.S. Chang The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases Mol. Cell. Biol. 21 2000 2259 2268
16. F. Grignan, S. De Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F.F. Ferrara, I. Zamir, C. Seiser, M.A. Lazar, S. Minucci, and P.G. Pelicci Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia Nature 391 1998 815 818
17. J.D. Licht AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML Oncogene 20 2001 5660 5679
18. J.R. Downing AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia Leukemia 15 2001 664 665
19. M. Bar-Ner, M. Mayer, V. Schirrmacher, and I. Vlodavsky Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix J. Cell Physiol. 128 1986 299 306
20. I. Vlodavsky, Y. Friedmann, M. Elkin, H. Aingorn, R. Atzmon, R. Ishai-Michaeli, M. Bitan, O. Pappo, T. Peretz, I. Michal, L. Spector, and I. Pecker Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis Nat. Med. 5 2001 793 802
21. C.S. Shelley, J.M. Teodoridis, H. Park, O.C. Farokhzad, E.P. Bottinger, and M.A. Arnaout During differentiation of the monocytic cell line U937, Pur alpha mediates induction of the CD11c beta 2 integrin gene promoter J. Immunol. 168 2002 3887 3893
22. J. Yahalom, E. Fibach, R. Bar-Tana, Z. Fuks, and I. Vlodavsky Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix Leuk. Res. 12 1988 711 717
23. I. Olsson, G. Bergh, M. Ehinger, and U. Gullberg Cell differentiation in acute myeloid leukemia Eur. J. Haematol. 57 1996 1 16
24. P.A. Marks, V.M. Richon, and R.A. Rifkind Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells J. Natl. Cancer Inst. 92 2000 1210 1216
25. C.R. Parish, D.R. Coombe, K.B. Jakobsen, F.A. Bennett, and P.A. Underwood Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases Int. J. Cancer 40 1987 511 518
26. T. Irimura, M. Nakajima, and G.L. Nicolson Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells Biochemistry 25 1986 5322 5328
27. Y. Matzner, I. Vlodavsky, R.I. Michaeli, and A. Eldor Selective inhibition of neutrophil activation by the subendothelial extracellular matrix: possible role in protection of the vessel wall during diapedesis Exp. Cell Res. 189 1990 233 240
28. A. Eldor, M. Bar-Ner, J. Yahalom, Z. Fuks, and I. Vlodavsky Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix Semin. Thromb. Hemost. 13 1987 475 488
29. A. Buda, and M. Pignatelli Genetics-cellular basis Br. Med. Bull. 64 2002 45 58
30. L.M. Kelly, and D.G. Gilliland Genetics of myeloid leukemias Annu. Rev. Genom. Hum. Genet. 3 2002 179 198
31. G. Dotti, E. Garattini, G. Borleri, K. Masuhara, O. Spinelli, T. Barbui, and A. Rambaldi Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity Br. J. Haematol. 105 1999 163 172
32. A. Melnick, and J.D. Licht Histone deacetylases as therapeutic targets in hematologic malignancies Curr. Opin. Hematol. 9 2002 322 332
33. G. Behre, P. Zhang, D.E. Zhang, and D.G. Tenen Analysis of the modulation of transcriptional activity in myelopoiesis and leukemogenesis Methods 17 1999 231 237
34. A.M. de Mestre, L.M. Khachigian, F.S. Santiago, M.A. Staykova, and M.D. Hulett Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1 J. Biol. Chem. 278 2003 50377 50385